Picture of WuXi Biologics (Cayman) logo

2269 — WuXi Biologics (Cayman) News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapHigh Flyer

Brief: Wuxi Biologics Secures FDA Pli Approval For Five Facilities, First For Commercial Pfs Line

July 22 (Reuters) - WuXi Biologics (Cayman) Inc 2269.HK:

WUXI BIOLOGICS SECURES FDA PLI APPROVAL FOR FIVE FACILITIES, FIRST FOR COMMERCIAL PFS LINE

Source text: ID:nPremPhDVa

Further company coverage: 2269.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on WuXi Biologics (Cayman)

See all news